NO20084577L - Probiotisk stamme og antimikrobielle peptider fra disse - Google Patents

Probiotisk stamme og antimikrobielle peptider fra disse

Info

Publication number
NO20084577L
NO20084577L NO20084577A NO20084577A NO20084577L NO 20084577 L NO20084577 L NO 20084577L NO 20084577 A NO20084577 A NO 20084577A NO 20084577 A NO20084577 A NO 20084577A NO 20084577 L NO20084577 L NO 20084577L
Authority
NO
Norway
Prior art keywords
peptide
antimicrobial
strain
st4sa
mundtii
Prior art date
Application number
NO20084577A
Other languages
English (en)
Norwegian (no)
Inventor
Leon Milner Theodore Dicks
Svetoslav Dimitrov Todorov
Hendriette Knoetze
Marelize Brink
Original Assignee
Cipla Medpro Res And Dev Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ZA200604035A external-priority patent/ZA200604035B/xx
Application filed by Cipla Medpro Res And Dev Pty Ltd filed Critical Cipla Medpro Res And Dev Pty Ltd
Publication of NO20084577L publication Critical patent/NO20084577L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20084577A 2006-05-28 2008-11-03 Probiotisk stamme og antimikrobielle peptider fra disse NO20084577L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200604035A ZA200604035B (en) 2005-05-31 2006-05-28 Improved grenade launcher
PCT/IB2007/051982 WO2007138538A2 (en) 2006-05-28 2007-05-25 Probiotic strain and antimicrobial peptide derived therefrom

Publications (1)

Publication Number Publication Date
NO20084577L true NO20084577L (no) 2008-12-19

Family

ID=38779065

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084577A NO20084577L (no) 2006-05-28 2008-11-03 Probiotisk stamme og antimikrobielle peptider fra disse

Country Status (13)

Country Link
US (2) US7951385B2 (https=)
EP (1) EP2021457B1 (https=)
JP (1) JP2009538614A (https=)
KR (1) KR101521123B1 (https=)
CN (1) CN101454440B (https=)
AP (1) AP2841A (https=)
AU (1) AU2007266675B2 (https=)
CA (1) CA2647161A1 (https=)
EA (1) EA017558B1 (https=)
IL (2) IL195520A0 (https=)
NO (1) NO20084577L (https=)
NZ (1) NZ571619A (https=)
WO (1) WO2007138538A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101521123B1 (ko) * 2006-05-28 2015-05-19 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드
US8357519B2 (en) * 2008-11-19 2013-01-22 The Ohio State University Methods and processes for producing esters
WO2011045764A1 (en) * 2009-10-15 2011-04-21 Cipla Medpro Research And Development (Pty) Ltd A product for delivering antimicrobially active substances to an infected site
JP5881017B2 (ja) * 2010-11-05 2016-03-09 国立大学法人広島大学 籾殻または玄米から単離された植物乳酸菌およびその利用
WO2012148891A1 (en) * 2011-04-29 2012-11-01 Evonik Degussa Corporation Peptide-lipid conjugates and uses thereof
RU2532227C1 (ru) * 2013-10-23 2014-10-27 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Штамм enterоcoccus mundtii, продуцирующий субстанцию пептидной природы с антилистериозной активностью
RU2599430C1 (ru) * 2015-07-23 2016-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" ШТАММ ЛАКТОБАКТЕРИЙ Enterococcus mundtii - ПРОДУЦЕНТ МОЛОЧНОЙ КИСЛОТЫ И АНТИБИОТИЧЕСКИХ ВЕЩЕСТВ
US9944960B2 (en) * 2015-11-17 2018-04-17 Premier Research Labs, Lp Process for microbial production of dihydrolipoic acid and extraction of dihydrolipoic acid with edible oils
CN105385636A (zh) * 2015-12-07 2016-03-09 江南大学 一株产细菌素的肠膜明串珠菌及其应用
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
EP3436041B1 (en) 2016-03-31 2023-05-24 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
KR101722255B1 (ko) * 2016-04-22 2017-04-03 주식회사 폴인브레드 쌀과 쌀누룩을 이용한 자연발효종 제조방법
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
AU2018336988B2 (en) * 2017-09-19 2023-06-22 Advaxis, Inc. Compositions and methods for lyophilization of bacteria or Listeria strains
WO2019151371A1 (ja) * 2018-01-31 2019-08-08 ニュートリー株式会社 肺炎球菌感染症の予防及び／又は治療剤
KR102076089B1 (ko) 2018-10-02 2020-02-11 서울대학교 산학협력단 니신 z 생산능이 우수한 락토코커스 락티스 서브스페시스 락티스 ldtm 6804 신균주(kctc 13564bp)
CN109456911B (zh) * 2018-10-10 2019-10-18 南京林业大学 一株蒙氏肠球菌HcM7及其应用
CN110846260B (zh) * 2019-12-18 2021-03-02 江南大学 一株降低生物胺的肉葡萄球菌及其应用
KR102951826B1 (ko) * 2023-01-18 2026-04-13 조선대학교산학협력단 오리 유래 항균 펩타이드로부터 설계된 신규 항균 펩타이드 및 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1084969A (ja) 1996-09-19 1998-04-07 Chemo Sero Therapeut Res Inst ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法
US7655775B2 (en) * 1997-09-05 2010-02-02 Canbiocin, Inc. Expression vectors for treating bacterial infections
AU7898700A (en) 1999-10-22 2001-05-08 Shanghai Bio Road Gene Development Ltd. A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
DE10105347A1 (de) * 2001-02-05 2002-08-22 Nutrinova Gmbh Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht
GB0125535D0 (en) 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
US6878373B2 (en) 2001-12-03 2005-04-12 Micropure Technologies, Inc. Probiotic composition containing Bacillus cereus RRRL B-30535
JP4111489B2 (ja) * 2002-05-23 2008-07-02 プリマハム株式会社 新規バクテリオシン
WO2004005492A2 (fr) * 2002-07-03 2004-01-15 Galina Gennadievna Alekhina Composition probiotique a base d'une souche d'enterocoques pour moyens de traitement et de prevention et procede de fabrication correspondant
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
ITBO20020564A1 (it) 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
KR101521123B1 (ko) * 2006-05-28 2015-05-19 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드

Also Published As

Publication number Publication date
AU2007266675A1 (en) 2007-12-06
AU2007266675B2 (en) 2012-09-06
US20110268703A1 (en) 2011-11-03
AP2841A (en) 2014-02-28
AP2008004626A0 (en) 2008-10-31
US20090297482A1 (en) 2009-12-03
CA2647161A1 (en) 2007-12-06
US8444998B2 (en) 2013-05-21
KR101521123B1 (ko) 2015-05-19
EP2021457B1 (en) 2015-02-11
NZ571619A (en) 2011-10-28
IL195520A0 (en) 2011-08-01
WO2007138538A3 (en) 2008-04-17
IL250634A0 (en) 2017-03-30
EA017558B1 (ru) 2013-01-30
KR20090023626A (ko) 2009-03-05
EA200802409A1 (ru) 2009-10-30
CN101454440A (zh) 2009-06-10
US7951385B2 (en) 2011-05-31
WO2007138538A2 (en) 2007-12-06
EP2021457A2 (en) 2009-02-11
CN101454440B (zh) 2013-05-29
JP2009538614A (ja) 2009-11-12

Similar Documents

Publication Publication Date Title
NO20084577L (no) Probiotisk stamme og antimikrobielle peptider fra disse
Peltier et al. Recent knowledge and innovations related to hexofuranosides: structure, synthesis and applications
Roos et al. Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae
WO2010093627A3 (en) Fibronectin type iii domain based scaffold compositions, methods and uses
BR112012033404A2 (pt) polipetídeo tendo ou auxiliando a atividade de degradação de material de carboidratos e uso dos mesmos.
CL2018000537A1 (es) Anticuerpo anti-factor d del complemento; polinucleótido codificante; vector que comprende dicho polinucleótido; célula húesped que comprende dicho vector; método de fabricación de anticuerpo; composición farmacéutica que lo comprende; uso del anticuerpo para tratar trastornos inflamatorios o trastornos oculares (divisional de cl 1001-2009).
WO2010051274A3 (en) Fibronectin type iii domain based scaffold compositions, methods and uses
BR112012033699A2 (pt) polipeptídeo tendo atividade beta-glicosidase e seus usos
AR061467A1 (es) Axmi-031 axmi-039 axmi-040 y axmi-049 una familia de nuevos genes de delta-endotoxinas y metodos para usarlos
AR064216A1 (es) Polipeptidos cristalinos de bacillus thuringiensis, polinucleotidos y composiciones de los mismos
Lee et al. Why?–Successful Pseudomonas aeruginosa clones with a focus on clone C
NO20080745L (no) Nye peptider for anvendelse i behandling av fedme
NO20062662L (no) Muteiner av fibroblast vekstfaktor 21
WO2011137319A3 (en) Stabilized fibronectin domain compositions, methods and uses
NO20092331L (no) LINGO-bindingsmolekyler og farmasoytisk anvendelse derav
MX2009004969A (es) Acido hialuronico reticulado y su metodo de produccion.
WO2008119567A8 (en) Cross-species-specific cd3-epsilon binding domain
BR112012033703A2 (pt) polipeptídeo tendo atividade beta-glicosidase e seus usos
PH12012501831B1 (en) Protein ipa1 related to plant architecture, its coding genes and uses
BR112012033714A2 (pt) polipeptídeo com atividade de acetil xilano esterase e seus usos.
BR0309570A (pt) Fatores camp quiméricos para vacinação contra infecção por streptococcus
BR112012033701A2 (pt) polipeptídeo tendo atividade de degradação de carbohidrato e seus usos
DK2040560T3 (da) Cysteingranuler og anvendelse deraf som bifidobacterium animalis lactis vækststimulanter
Von Ossowski Novel molecular insights about lactobacillar sortase-dependent piliation
Kriaa et al. SP-1, a serine protease from the gut microbiota, influences colitis and drives intestinal dysbiosis in mice

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: CIPLA-MEDPRO (PTY) LTD., ZA

FC2A Withdrawal, rejection or dismissal of laid open patent application